Urogenital cultures and preterm birth in women with cervical cerclage: a single center retrospective cohort study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
26 Apr 2024
Historique:
received: 08 04 2023
accepted: 11 04 2024
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 26 4 2024
Statut: epublish

Résumé

The leading hypothesis of the pathogenesis of cervical insufficiency suggests a role of cervical inflammation. Urogenital tract infections could play a causative role in this process. To test this hypothesis in women with a cervical cerclage, we aimed to retrospectively examine the relationship between gestational age (GA) at delivery and positive urogenital cultures. This single center retrospective study reviewed the records of all women with a singleton pregnancy that underwent cervical cerclage (n = 203) between 2010 and 2020 at the University Hospital of Leuven, Belgium. Transvaginal cerclages were categorized as history indicated (TVC I, n = 94), ultrasound indicated (TVC II, n = 79) and clinically indicated (TVC III, n = 20). Additionally, ten women received transabdominal cerclage (TAC). Urogenital cultures (vaginal and urine) were taken before and after cerclage with 4-week intervals. Urogenital cultures were reported 'positive' if urine and/or vaginal cultures showed significant growth of a microorganism. Treatment decision depended on culture growth and clinical presentation. The primary aim was to evaluate the association between the urogenital culture results and the GA at delivery, for each of the cerclage groups. Secondarily, to investigate the effect of antibiotic treatment of positive cultures on GA at delivery. Positive pre-cerclage urogenital cultures were associated with lower GA at delivery in TVC III (positive culture 26w4d ± 40d vs. negative 29w6d ± 54d, p = 0.036). For TVC I, GA at delivery was longer when pre-cerclage urogenital cultures were positive (positive culture 38w0d ± 26d vs. negative 35w4d ± 42d, p = 0.035). Overall post-cerclage urogenital cultures status was not associated with a different GA at delivery. Treating patients with pre- or post-cerclage positive urogenital cultures did also not change GA at delivery. Positive urogenital cultures taken before clinically indicated cerclage intervention may be associated with lower GA at delivery. However, there seems to be no benefit of antibiotic treatment or routine urogenital cultures during follow-up of asymptomatic women after cerclage placement.

Sections du résumé

BACKGROUND BACKGROUND
The leading hypothesis of the pathogenesis of cervical insufficiency suggests a role of cervical inflammation. Urogenital tract infections could play a causative role in this process. To test this hypothesis in women with a cervical cerclage, we aimed to retrospectively examine the relationship between gestational age (GA) at delivery and positive urogenital cultures.
METHODS METHODS
This single center retrospective study reviewed the records of all women with a singleton pregnancy that underwent cervical cerclage (n = 203) between 2010 and 2020 at the University Hospital of Leuven, Belgium. Transvaginal cerclages were categorized as history indicated (TVC I, n = 94), ultrasound indicated (TVC II, n = 79) and clinically indicated (TVC III, n = 20). Additionally, ten women received transabdominal cerclage (TAC). Urogenital cultures (vaginal and urine) were taken before and after cerclage with 4-week intervals. Urogenital cultures were reported 'positive' if urine and/or vaginal cultures showed significant growth of a microorganism. Treatment decision depended on culture growth and clinical presentation. The primary aim was to evaluate the association between the urogenital culture results and the GA at delivery, for each of the cerclage groups. Secondarily, to investigate the effect of antibiotic treatment of positive cultures on GA at delivery.
RESULTS RESULTS
Positive pre-cerclage urogenital cultures were associated with lower GA at delivery in TVC III (positive culture 26w4d ± 40d vs. negative 29w6d ± 54d, p = 0.036). For TVC I, GA at delivery was longer when pre-cerclage urogenital cultures were positive (positive culture 38w0d ± 26d vs. negative 35w4d ± 42d, p = 0.035). Overall post-cerclage urogenital cultures status was not associated with a different GA at delivery. Treating patients with pre- or post-cerclage positive urogenital cultures did also not change GA at delivery.
CONCLUSION CONCLUSIONS
Positive urogenital cultures taken before clinically indicated cerclage intervention may be associated with lower GA at delivery. However, there seems to be no benefit of antibiotic treatment or routine urogenital cultures during follow-up of asymptomatic women after cerclage placement.

Identifiants

pubmed: 38671377
doi: 10.1186/s12884-024-06509-9
pii: 10.1186/s12884-024-06509-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

324

Subventions

Organisme : Fonds Wetenschappelijk Onderzoek
ID : 1803311N

Informations de copyright

© 2024. The Author(s).

Références

World Health Organization. WHO recommendations on interventions to improve preterm birth outcomes. 2015. https://www.who.int/publications/i/item/9789241508988 . Accessed 12 March 2023.
Devlieger R, Goemaes R, Laubach M. Perinatale gezondheid in Vlaanderen – Jaar 2020. Brussel: Studiecentrum voor Perinatale Epidemiologie. 2021; 1–85.
Morgan AS, Mendonça M, Thiele N, David AL. Management and outcomes of extreme preterm birth. BMJ. 2022;376:1–9.
Drakeley AJ, Quenby S, Farquharson RG. Mid-trimester loss - Appraisal of a screening protocol. Hum Reprod. 1998;13(7):1975–80.
doi: 10.1093/humrep/13.7.1975 pubmed: 9740460
Joubert M, Sibiude J, Bounan S, Mandelbrot L. Mid-trimester miscarriage and subsequent pregnancy outcomes: the role of cervical insufficiency in a cohort of 175 cases. J Matern Neonatal Med. 2022;35(24):4698–703.
doi: 10.1080/14767058.2020.1861600
Lidegaard O. Cervical incompetence and cerclage in Denmark 1980–1990 a register based epidemiological survey. Acta Obstet Gynecol Scand. 1994;37(4):35–8.
doi: 10.3109/00016349409013390
Barinov SV, Artymuk NV, Novikova ON, Shamina IV, Tirskaya YI, Belinina AA, et al. Analysis of risk factors and predictors of pregnancy loss and strategies for the management of cervical insufficiency in pregnant women at a high risk of preterm birth. J Matern Neonatal Med. 2021;34(13):2071–9.
doi: 10.1080/14767058.2019.1656195
Vink J, Feltovich H. Cervical etiology of spontaneous preterm birth. Semin Fetal Neonatal Med. 2016;21(2):106–12.
doi: 10.1016/j.siny.2015.12.009 pubmed: 26776146 pmcid: 4798922
Roman A, Suhag A, Berghella V. Overview of cervical insufficiency: diagnosis, etiologies, and risk factors. Clin Obstet Gynecol. 2016;59(2):237–40.
doi: 10.1097/GRF.0000000000000184 pubmed: 27015229
Cunnington M, Kortsalioudaki C, Heath P. Genitourinary pathogens and preterm birth. Curr Opin Infect Dis. 2013;26:219–30.
doi: 10.1097/QCO.0b013e328360dc31 pubmed: 23612500
Obert R, Oldenberg LG, Ohn J, Auth CH, Ndrews WA. Intrauterine infection and Preterm Delivery. N Engl J Med. 2000;342:1500–7.
doi: 10.1056/NEJM200005183422007
Digiulio DB, Gervasi M, Romero R, Vaisbuch E, Mazaki-Tovi S, Kusanovic JP, et al. Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses. J Perinat Med. 2010;38(5):495–502.
doi: 10.1515/jpm.2010.076 pubmed: 20482466 pmcid: 2962935
Care A, Nevitt SJ, Medley N, Donegan S, Goodfellow L, Hampson L, et al. Interventions to prevent spontaneous Preterm Birth in women with singleton pregnancy who are at high risk: systematic review and network Meta-analysis. Obstet Gynecol Surv. 2022;77(8):463–4.
doi: 10.1097/01.ogx.0000852904.48412.13
Alfirevic Z, Stampalija T, Medley N. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Reviews. 2017;2017(6):CD008991.
Shennan A, Chandiramani M, Bennett P, David AL, Girling J, Ridout A et al. MAVRIC: a multicenter randomized controlled trial of transabdominal vs transvaginal cervical cerclage. Am J Obstet Gynecol. 2020;222(3):261.e1-261.e9.
Chatzakis C, Efthymiou A, Sotiriadis A, Makrydimas G. Emergency cerclage in singleton pregnancies with painless cervical dilatation: a meta-analysis. Acta Obstet Gynecol Scand. 2020;99(11):1444–57.
doi: 10.1111/aogs.13968 pubmed: 32757297
Gundabattula SR, Marakani LR, Dasari S, Surampudi K, Pochiraju M, Nirmalan PK. Outcomes of pregnancy in women who had rescue cerclage for cervical insufficiency: a single-center retrospective study. J Obstet Gynaecol Res. 2013;39(8):1293–300.
doi: 10.1111/jog.12059 pubmed: 23800290
Kanbayashi S, Sato Y, Taga A, Satake Y, Emoto I, Maruyama S, et al. Positive vaginal culture at rescue cerclage predicts subsequent preterm delivery. J maternal-fetal Neonatal Med. 2018;31(9):1161–5.
doi: 10.1080/14767058.2017.1311313
Jin W, Hughes K, Sim S, Shemer S, Sheehan PM. Abnormal vaginal flora and spontaneous preterm birth in high-risk singleton pregnancies with cervical cerclage. J maternal-fetal Neonatal Med. 2022;35(25):9983–90.
doi: 10.1080/14767058.2022.2081802
Kunpalin Y, Burul G, Greenwold N, Tetteh A, Casagrandi D, Warner D, et al. Factors associated with preterm birth in women undergoing cervical cerclage. Eur J Obstet Gynecol Reproductive Biology. 2020;251:141–5.
doi: 10.1016/j.ejogrb.2020.05.027
Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Invest. 2008;38(2):50–7.
doi: 10.1111/j.1365-2362.2008.02009.x pubmed: 18826482
Akeno K, Ohashi M, Furukawa S, Sameshima H. Cerclage in surgically shortened uterine cervix and pregnancy outcome: a retrospective comparison between the abdominal and vaginal procedures. J Obstet Gynaecol Res. 2022;48(12):3087–92.
doi: 10.1111/jog.15428 pubmed: 36110090
Cunnington M, Kortsalioudaki C, Heath P. Genitourinary pathogens and preterm birth. Curr Opin Infect Dis. 2013;26(3):219–30.
doi: 10.1097/QCO.0b013e328360dc31 pubmed: 23612500
Nasioudis D, Linhares IM, Ledger WJ, Witkin SS. Bacterial vaginosis: a critical analysis of current knowledge. BJOG: Int J Obstet Gynecol. 2017;124(1):61–9.
doi: 10.1111/1471-0528.14209
Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003;189(1):139–47.
doi: 10.1067/mob.2003.339 pubmed: 12861153
Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013.
Gómez-Castellano M, Sabonet-Morente L, González-Mesa E, Jiménez-López JS. A Three-Step Procedure for Emergency Cerclage: gestational and neonatal outcomes. Int J Environ Res Public Health. 2022;19(5):2636.
doi: 10.3390/ijerph19052636 pubmed: 35270320 pmcid: 8909863

Auteurs

Evelien Seys (E)

Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium.

Ann-Sophie Page (AS)

Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium.

Jan Deprest (J)

Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium.
Cluster Woman and Child, Department of Development and Regeneration, Group Biomedical Sciences, KU Leuven Herestraat 49, Leuven, 3000, Belgium.

Lore Lannoo (L)

Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium.
Cluster Woman and Child, Department of Development and Regeneration, Group Biomedical Sciences, KU Leuven Herestraat 49, Leuven, 3000, Belgium.

Kristel van Calsteren (K)

Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium.
Cluster Woman and Child, Department of Development and Regeneration, Group Biomedical Sciences, KU Leuven Herestraat 49, Leuven, 3000, Belgium.

Roland Devlieger (R)

Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium.
Cluster Woman and Child, Department of Development and Regeneration, Group Biomedical Sciences, KU Leuven Herestraat 49, Leuven, 3000, Belgium.

Johannes van der Merwe (J)

Department of Obstetrics and Gynecology, Division Woman and Child, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium. hannes.vandermerwe@uzleuven.be.
Cluster Woman and Child, Department of Development and Regeneration, Group Biomedical Sciences, KU Leuven Herestraat 49, Leuven, 3000, Belgium. hannes.vandermerwe@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH